Literature DB >> 18719387

RecQ family helicases in genome stability: lessons from gene disruption studies in DT40 cells.

Masayuki Seki1, Makoto Otsuki, Yutaka Ishii, Shusuke Tada, Takemi Enomoto.   

Abstract

Cells of all living organisms have evolved complex mechanisms to maintain genome stability. There is increasing evidence that spontaneous genomic instability occurs primarily during DNA replication. RecQ DNA helicases function during DNA replication and are essential for the maintenance of genome stability. In human cells, there exist five RecQ DNA helicases, and mutations of three of these helicases, encoded by the BLM, WRN and RECQL4 genes, give rise to the cancer predisposition disorders, Bloom syndrome (BS), Werner syndrome (WS) and Rothmund-Thomson syndrome (RTS), respectively. Individuals suffering from WS and RTS also show premature aging phenotypes. Although the two remaining helicases, RECQL1 and RECQL5, have not yet been associated with heritable human diseases, a single nucleotide polymorphism of RECQL1 is associated with reduced survival of pancreatic cancer, and RecQl5 knockout mice show a predisposition to cancer. Here, we review the functions of eukaryotic RecQ helicases, focusing primarily on BLM in the maintenance of genome stability through various pathways of nucleic acid metabolism and with special reference to DNA replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18719387     DOI: 10.4161/cc.7.16.6462

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  15 in total

Review 1.  The RecQ DNA helicases in DNA repair.

Authors:  Kara A Bernstein; Serge Gangloff; Rodney Rothstein
Journal:  Annu Rev Genet       Date:  2010       Impact factor: 16.830

Review 2.  RecQ4: the second replicative helicase?

Authors:  Christopher Capp; Jianhong Wu; Tao-Shih Hsieh
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-06       Impact factor: 8.250

3.  A novel survival multifactor dimensionality reduction method for detecting gene-gene interactions with application to bladder cancer prognosis.

Authors:  Jiang Gui; Jason H Moore; Karl T Kelsey; Carmen J Marsit; Margaret R Karagas; Angeline S Andrew
Journal:  Hum Genet       Date:  2010-10-28       Impact factor: 4.132

Review 4.  Helicase Mechanisms During Homologous Recombination in Saccharomyces cerevisiae.

Authors:  J Brooks Crickard; Eric C Greene
Journal:  Annu Rev Biophys       Date:  2019-03-11       Impact factor: 12.981

5.  Regulatory control of Sgs1 and Dna2 during eukaryotic DNA end resection.

Authors:  Chaoyou Xue; Weibin Wang; J Brooks Crickard; Corentin J Moevus; Youngho Kwon; Patrick Sung; Eric C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-08       Impact factor: 11.205

6.  Hrq1 functions independently of Sgs1 to preserve genome integrity in Saccharomyces cerevisiae.

Authors:  Do-Hee Choi; Rina Lee; Sung-Hun Kwon; Sung-Ho Bae
Journal:  J Microbiol       Date:  2013-03-02       Impact factor: 3.422

Review 7.  At loose ends: resecting a double-strand break.

Authors:  Kara A Bernstein; Rodney Rothstein
Journal:  Cell       Date:  2009-05-29       Impact factor: 41.582

8.  Drosophila RecQ4 has a 3'-5' DNA helicase activity that is essential for viability.

Authors:  Christopher Capp; Jianhong Wu; Tao-shih Hsieh
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

Review 9.  Distinct roles of RECQ1 in the maintenance of genomic stability.

Authors:  Yuliang Wu; Robert M Brosh
Journal:  DNA Repair (Amst)       Date:  2010-01-12

10.  Relative contribution of four nucleases, CtIP, Dna2, Exo1 and Mre11, to the initial step of DNA double-strand break repair by homologous recombination in both the chicken DT40 and human TK6 cell lines.

Authors:  Nguyen Ngoc Hoa; Remi Akagawa; Tomomi Yamasaki; Kouji Hirota; Kentaro Sasa; Toyoaki Natsume; Junya Kobayashi; Tetsushi Sakuma; Takashi Yamamoto; Kenshi Komatsu; Masato T Kanemaki; Yves Pommier; Shunichi Takeda; Hiroyuki Sasanuma
Journal:  Genes Cells       Date:  2015-11-02       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.